Not Your Father s Farmland Market (even if he still owns the farm.)
|
|
- Aubrey Martin
- 5 years ago
- Views:
Transcription
1 Not Your Father s Farmland Market (even if he still owns the farm.) DTN Conference December 2016 Chicago, Illinois Bruce J. Sherrick, Ph.D. TIAA Center for Farmland Research, University of Illinois Advancing Farmland Markets through Research and Information
2 TIAA Center for Farmland Research Advancing Farmland Markets through Research and Information C o n t e x t Goals: improve accuracy and understanding of asset class, and to provide unbiased research and useful tools for those involved with farmland investments. Tools and articles at:
3 Balance Sheet of Ag Sector -- US ($ millions, except ratios - source ERS-USDA) Farm Assets 278,823 1,000, ,609 1,203,215 2,161,362 2,310,640 2,777,810 2,861,816 Real Estate 202, , , ,428 1,651,379 1,795,126 2,252,907 2,342,314 Non Real Estate 76, , , , , , , ,503 Farm Debt 48, , , , , , , ,261 Real Estate 27,238 85,272 67,633 84, , , , ,091 Non Real Estate 21,263 77,160 63,483 79, , , , ,170 Equity 230, , ,493 1,039,285 1,882,431 2,016,168 2,462,835 2,497,555 Selected Indicators Debt/Equity 21.1% 19.4% 18.5% 15.8% 14.8% 14.6% 12.8% 14.6% Debt/Assets 17.4% 16.2% 15.6% 13.6% 12.9% 12.7% 11.3% 12.7% Real Estate/Equity 87.9% 93.4% 87.3% 91.1% 87.7% 89.0% 91.5% 93.8% Real Estate/Assets 72.6% 78.2% 73.7% 78.7% 76.4% 77.7% 81.1% 81.8% Real Estate D/Total D 56.2% 52.5% 51.6% 51.7% 55.2% 56.8% 58.7% 56.3%
4 Ag Sector Balance Sheet -- US C o n t e x t Farmland represents 80+% of farm assets Farm real estate debt only 57% of total farm debt Low aggregate leverage (approx. 13% D/A) Growth rates , continuous compounding: Assets --5.3% Real Estate % Debt 4.2% Equity 5.6% Absence of active equity market. Some key efforts underway. Ag Balance sheet compared to corporate sector vastly different, especially in financial structure. Early stage financialization.
5 Yield Curve August 2001-October 21, 2016 (weekly) Sept. 19, 2008 Liquidity puddle Rate hike 12/15
6 Does the farmland market make sense? Historic comparison of implied cap rate and CMT-10 One period in 1980 s where conditions that might be considered bubble formation existed. Implied asset value from capitalization of income to q2:16. Recent asset values show that the market did not consider income levels in recent years to be permanent
7 Farmland Returns in context Annual Ave. Standard Coefficient Asset/Index Return Deviation of Variation Correlation US Ave Farm (all) 10.54% 6.41% S&P % 16.74% NASDAQ 9.71% 25.53% TCM10Y 6.67% 2.88% AAA 7.79% 2.50% Mort30F 8.35% 3.06% Gold 7.40% 23.04% All REITS 9.09% 20.34% CPI 4.00% 2.86%
8 Farmland Returns in context Annual Ave. Standard Coefficient Asset/Index Return Deviation of Variation Correlation US Ave Farm (all) 8.53% 5.27% S&P % 16.09% NASDAQ 9.71% 25.53% TCM10Y 6.44% 3.18% AAA 7.67% 2.79% Mort30F 8.22% 3.36% Gold 2.02% 16.29% All REITS 10.33% 17.31% CPI 3.14% 2.11%
9 Farmland Returns in context Annual Ave. Standard Coefficient Asset/Index Return Deviation of Variation Correlation US Ave Farm (all) 9.27% 3.70% S&P % 17.55% NASDAQ 9.23% 27.44% TCM10Y 4.85% 1.80% AAA 6.25% 1.51% Mort30F 6.50% 1.70% Gold 3.76% 14.54% All REITS 9.77% 19.04% CPI 2.44% 1.13%
10 Farmland Returns in context Annual Ave. Standard Coefficient Asset/Index Return Deviation of Variation Correlation US Ave Farm (all) 9.27% 4.54% S&P % 18.80% NASDAQ 1.30% 27.47% TCM10Y 3.71% 1.15% AAA 5.33% 1.06% Mort30F 5.48% 1.23% Gold 8.10% 15.45% All REITS 11.01% 19.77% CPI 2.15% 1.03%
11 Annualized Return Buy (beginning of year) Farmland: time and holding periods Iowa Sell (end of year) % 16.3% 21.6% 23.0% 24.8% 26.8% 24.6% 24.1% 23.9% 22.8% 20.6% 18.2% 16.3% 12.8% 10.8% 10.0% 10.9% 11.5% 11.3% 11.3% 11.2% 11.3% 11.3% 11.3% 11.4% 11.5% 11.5% 11.4% 11.3% 11.2% 11.1% 11.0% 11.1% 11.4% 11.5% 11.7% 11.9% 11.5% 11.7% 12.0% 12.2% 12.4% 12.4% 12.0% % 26.0% 26.4% 27.8% 29.8% 26.6% 25.7% 25.3% 23.9% 21.3% 18.6% 16.6% 12.8% 10.6% 9.8% 10.8% 11.4% 11.2% 11.2% 11.1% 11.2% 11.2% 11.2% 11.3% 11.5% 11.5% 11.4% 11.2% 11.1% 11.0% 11.0% 11.1% 11.4% 11.4% 11.6% 11.8% 11.5% 11.6% 12.0% 12.2% 12.4% 12.4% 12.0% % 30.0% 30.7% 32.5% 28.0% 26.8% 26.2% 24.5% 21.5% 18.5% 16.3% 12.2% 10.0% 9.1% 10.2% 10.9% 10.7% 10.8% 10.7% 10.8% 10.9% 10.9% 11.0% 11.2% 11.2% 11.1% 10.9% 10.8% 10.7% 10.7% 10.8% 11.1% 11.2% 11.4% 11.6% 11.3% 11.4% 11.8% 12.0% 12.2% 12.2% 11.8% % 29.7% 32.3% 26.9% 25.7% 25.1% 23.4% 20.2% 17.0% 14.8% 10.5% 8.3% 7.5% 8.7% 9.6% 9.5% 9.6% 9.6% 9.7% 9.9% 9.9% 10.1% 10.3% 10.3% 10.3% 10.2% 10.1% 10.0% 10.0% 10.1% 10.5% 10.6% 10.8% 11.1% 10.7% 10.9% 11.2% 11.5% 11.7% 11.7% 11.3% % 34.9% 26.7% 25.3% 24.7% 22.7% 19.2% 15.8% 13.5% 8.9% 6.7% 6.0% 7.4% 8.4% 8.4% 8.6% 8.6% 8.8% 9.0% 9.1% 9.3% 9.6% 9.7% 9.6% 9.5% 9.5% 9.4% 9.4% 9.6% 10.0% 10.1% 10.3% 10.6% 10.2% 10.4% 10.8% 11.1% 11.3% 11.4% 11.0% % 24.1% 23.0% 22.9% 20.9% 17.2% 13.7% 11.4% 6.6% 4.4% 3.9% 5.6% 6.8% 6.8% 7.2% 7.3% 7.6% 7.8% 8.0% 8.3% 8.6% 8.7% 8.7% 8.7% 8.6% 8.6% 8.7% 8.8% 9.3% 9.4% 9.7% 10.0% 9.6% 9.9% 10.3% 10.6% 10.8% 10.9% 10.5% % 16.3% 18.3% 17.0% 13.4% 10.1% 8.0% 3.3% 1.3% 1.0% 3.1% 4.5% 4.8% 5.3% 5.5% 5.9% 6.3% 6.6% 6.9% 7.3% 7.5% 7.6% 7.5% 7.6% 7.6% 7.7% 7.9% 8.4% 8.6% 8.9% 9.2% 8.9% 9.1% 9.5% 9.9% 10.1% 10.2% 9.8% % 21.7% 18.8% 13.8% 9.7% 7.4% 2.1% 0.0% -0.2% 2.2% 3.9% 4.2% 4.8% 5.1% 5.6% 6.0% 6.3% 6.6% 7.1% 7.3% 7.4% 7.4% 7.4% 7.4% 7.5% 7.8% 8.3% 8.4% 8.8% 9.1% 8.8% 9.0% 9.5% 9.8% 10.1% 10.2% 9.8% % 17.8% 11.6% 7.1% 4.9% -0.7% -2.7% -2.5% 0.3% 2.3% 2.8% 3.5% 4.0% 4.5% 5.0% 5.4% 5.9% 6.4% 6.6% 6.7% 6.8% 6.8% 6.9% 7.0% 7.3% 7.8% 8.0% 8.3% 8.7% 8.4% 8.7% 9.1% 9.5% 9.8% 9.9% 9.5% % 6.5% 2.4% 0.9% -4.8% -6.3% -5.6% -2.1% 0.3% 1.0% 2.0% 2.6% 3.3% 3.9% 4.4% 4.9% 5.5% 5.8% 6.0% 6.0% 6.1% 6.2% 6.4% 6.7% 7.3% 7.5% 7.9% 8.3% 7.9% 8.2% 8.7% 9.1% 9.4% 9.5% 9.1% % -2.6% -2.9% -8.9% -9.8% -8.5% -4.1% -1.2% -0.3% 0.9% 1.6% 2.5% 3.2% 3.8% 4.4% 5.0% 5.4% 5.6% 5.7% 5.8% 5.9% 6.1% 6.4% 7.0% 7.3% 7.7% 8.1% 7.7% 8.1% 8.6% 9.0% 9.3% 9.4% 9.0% % -4.3% -11.6% -12.1% -10.1% -4.8% -1.4% -0.3% 1.0% 1.8% 2.7% 3.5% 4.1% 4.7% 5.4% 5.7% 5.9% 6.0% 6.1% 6.2% 6.4% 6.7% 7.3% 7.6% 8.0% 8.4% 8.0% 8.4% 8.9% 9.3% 9.6% 9.7% 9.3% % -14.7% -14.3% -11.3% -4.7% -0.7% 0.4% 1.8% 2.6% 3.5% 4.3% 4.9% 5.5% 6.2% 6.5% 6.6% 6.7% 6.7% 6.8% 7.0% 7.3% 7.9% 8.2% 8.6% 9.0% 8.6% 8.9% 9.4% 9.8% 10.2% 10.2% 9.8% % -19.3% -13.8% -5.1% -0.2% 1.1% 2.6% 3.4% 4.3% 5.1% 5.7% 6.3% 6.9% 7.2% 7.3% 7.3% 7.4% 7.4% 7.6% 7.9% 8.5% 8.7% 9.1% 9.5% 9.1% 9.4% 9.9% 10.4% 10.7% 10.7% 10.2% % -7.7% 2.5% 7.1% 7.2% 8.0% 8.2% 8.7% 9.1% 9.3% 9.6% 10.1% 10.2% 10.1% 9.9% 9.8% 9.7% 9.7% 9.9% 10.5% 10.6% 11.0% 11.3% 10.8% 11.1% 11.6% 11.9% 12.2% 12.2% 11.6% % 11.6% 15.0% 13.1% 12.9% 12.3% 12.3% 12.3% 12.2% 12.3% 12.5% 12.4% 12.1% 11.8% 11.5% 11.3% 11.2% 11.4% 11.9% 12.0% 12.3% 12.6% 12.0% 12.2% 12.7% 13.0% 13.3% 13.2% 12.6% % 24.4% 18.5% 16.9% 15.3% 14.8% 14.4% 14.0% 13.9% 14.1% 13.8% 13.4% 12.9% 12.5% 12.3% 12.1% 12.2% 12.7% 12.8% 13.0% 13.3% 12.7% 12.9% 13.3% 13.7% 13.9% 13.8% 13.2% % 14.6% 13.8% 12.6% 12.6% 12.5% 12.3% 12.4% 12.8% 12.6% 12.2% 11.8% 11.5% 11.3% 11.2% 11.4% 12.0% 12.0% 12.4% 12.7% 12.0% 12.3% 12.8% 13.2% 13.4% 13.4% 12.7% % 9.8% 9.6% 10.3% 10.7% 10.8% 11.1% 11.6% 11.6% 11.3% 10.9% 10.7% 10.5% 10.5% 10.7% 11.4% 11.5% 11.8% 12.2% 11.5% 11.8% 12.4% 12.8% 13.0% 13.0% 12.4% % 10.7% 11.2% 11.5% 11.4% 11.7% 12.2% 12.1% 11.7% 11.3% 11.0% 10.8% 10.7% 10.9% 11.6% 11.7% 12.1% 12.5% 11.8% 12.0% 12.6% 13.0% 13.3% 13.3% 12.5% % 10.7% 11.2% 11.2% 11.6% 12.2% 12.1% 11.7% 11.2% 10.8% 10.6% 10.6% 10.8% 11.6% 11.7% 12.1% 12.5% 11.7% 12.0% 12.6% 13.1% 13.3% 13.3% 12.6% % 12.3% 11.9% 12.2% 12.9% 12.6% 12.0% 11.4% 11.0% 10.8% 10.7% 10.9% 11.8% 11.9% 12.3% 12.7% 11.9% 12.2% 12.8% 13.3% 13.5% 13.5% 12.7% % 11.8% 12.2% 13.0% 12.7% 12.0% 11.3% 10.9% 10.6% 10.5% 10.8% 11.7% 11.9% 12.3% 12.7% 11.9% 12.2% 12.9% 13.3% 13.6% 13.6% 12.7% % 12.2% 13.3% 12.8% 11.9% 11.1% 10.7% 10.4% 10.3% 10.7% 11.7% 11.8% 12.3% 12.8% 11.8% 12.2% 12.9% 13.4% 13.7% 13.6% 12.8% % 13.1% 14.3% 13.3% 12.1% 11.1% 10.6% 10.3% 10.2% 10.6% 11.7% 11.9% 12.4% 12.9% 11.9% 12.2% 13.0% 13.5% 13.8% 13.8% 12.8% % 13.4% 11.8% 10.6% 10.1% 9.9% 9.8% 10.3% 11.6% 11.8% 12.3% 12.9% 11.8% 12.2% 13.0% 13.5% 13.9% 13.8% 12.8% % 11.3% 9.9% 9.1% 8.8% 8.8% 8.9% 9.6% 11.1% 11.3% 12.0% 12.7% 11.5% 11.9% 12.8% 13.4% 13.8% 13.7% 12.7% % 7.9% 7.9% 8.1% 8.4% 9.3% 11.1% 11.3% 12.1% 12.8% 11.5% 12.0% 12.9% 13.5% 13.9% 13.8% 12.8% % 7.3% 7.6% 8.0% 8.4% 9.4% 11.5% 11.7% 12.5% 13.3% 11.8% 12.3% 13.3% 13.9% 14.3% 14.2% 13.0% % 8.3% 8.7% 10.0% 12.3% 12.5% 13.3% 14.0% 12.3% 12.8% 13.9% 14.5% 14.9% 14.7% 13.4% % 8.8% 9.2% 10.7% 13.5% 13.5% 14.2% 14.9% 12.9% 13.4% 14.5% 15.1% 15.5% 15.3% 13.8% % 11.7% 15.1% 14.7% 15.4% 16.0% 13.5% 14.0% 15.1% 15.8% 16.1% 15.8% 14.2% % 13.7% 17.9% 16.4% 16.8% 17.3% 14.1% 14.6% 15.8% 16.5% 16.8% 16.4% 14.6% % 17.7% 17.9% 18.2% 14.2% 14.8% 16.1% 16.9% 17.1% 16.7% 14.7% % Sold 13.4% 15.7% 16.9% 12.3% 13.3% 15.2% 16.1% 16.5% 16.0% 14.0% 2007 Bought 18.2% 18.7% 11.9% 13.3% 15.5% 16.6% 17.0% 16.4% 14.0% -30% % 8.9% 11.7% 14.9% 16.2% 16.8% 16.1% 13.5% % 8.1% 13.4% 15.5% 16.2% 15.6% 12.7% % 21.1% 21.4% 20.9% 19.2% 15.1% % 23.4% 22.0% 19.6% 14.6% (Illinois ) % 20.6% 17.9% 12.2% %--20% -20%--10% -10%-0% 0%-10% 10%-20% 20%-30% 30%-30% 19.4% 15.9% 9.1% % 4.3% %
12 Ave. Annual Return Average Annual return Farmland risk stability measures Holding period length: % 10% 8% 25 yr 20 yr 15 yr 10 yr 5 yr 3 yr 2 yr 1 yr 6% 4% 2% 0% 0% 2% 4% 6% 8% 10% 12% St.Dev. of Returns
13 Annualized Return Buy (beginning of year) S&P 500: time and holding periods S&P500 Sell (end of year) % -3.7% -15.7% -6.5% -2.1% -3.9% -3.2% -1.5% 1.0% -0.2% 1.0% 2.2% 2.1% 3.5% 4.2% 4.0% 4.5% 5.5% 4.8% 5.6% 5.6% 5.6% 5.3% 6.2% 6.7% 7.4% 8.0% 8.3% 7.6% 6.8% 5.5% 6.0% 6.1% 6.0% 6.2% 6.1% 4.1% 4.5% 4.7% 4.5% 4.7% 5.2% 5.3% 5.2% % -27.6% -12.6% -5.9% -7.2% -5.9% -3.5% -0.6% -1.7% -0.3% 1.1% 1.1% 2.7% 3.4% 3.3% 3.9% 4.9% 4.3% 5.2% 5.1% 5.2% 4.9% 5.9% 6.4% 7.1% 7.7% 8.1% 7.3% 6.5% 5.2% 5.7% 5.8% 5.7% 5.9% 5.9% 3.8% 4.2% 4.4% 4.3% 4.5% 5.0% 5.1% 5.0% % -9.2% -1.0% -4.0% -3.0% -0.7% 2.4% 0.7% 2.1% 3.4% 3.2% 4.8% 5.4% 5.2% 5.6% 6.7% 5.8% 6.7% 6.6% 6.6% 6.2% 7.2% 7.6% 8.4% 9.0% 9.3% 8.5% 7.6% 6.2% 6.7% 6.8% 6.6% 6.8% 6.7% 4.5% 4.9% 5.1% 5.0% 5.2% 5.7% 5.8% 5.6% % 22.4% 9.5% 7.4% 8.2% 10.5% 7.3% 8.1% 8.9% 8.1% 9.4% 9.8% 9.2% 9.3% 10.3% 9.1% 9.9% 9.6% 9.4% 8.9% 9.8% 10.1% 10.8% 11.3% 11.6% 10.6% 9.6% 8.1% 8.6% 8.6% 8.4% 8.5% 8.3% 6.0% 6.4% 6.6% 6.4% 6.5% 7.0% 7.1% 6.9% % 1.6% 1.4% 3.9% 7.4% 4.3% 5.6% 6.8% 6.2% 7.8% 8.3% 7.8% 8.1% 9.1% 8.0% 8.9% 8.6% 8.5% 8.0% 9.0% 9.4% 10.1% 10.7% 11.0% 10.0% 9.0% 7.4% 7.9% 8.0% 7.8% 7.9% 7.8% 5.4% 5.8% 6.0% 5.8% 6.0% 6.5% 6.6% 6.4% % -5.8% -0.3% 5.0% 1.8% 3.7% 5.4% 4.9% 6.8% 7.4% 6.9% 7.3% 8.5% 7.4% 8.4% 8.1% 8.0% 7.5% 8.5% 9.0% 9.8% 10.4% 10.7% 9.7% 8.7% 7.0% 7.6% 7.6% 7.5% 7.6% 7.5% 5.0% 5.5% 5.7% 5.5% 5.7% 6.2% 6.3% 6.1% % 6.2% 11.5% 5.6% 7.2% 8.6% 7.5% 9.4% 9.9% 9.1% 9.3% 10.5% 9.0% 10.0% 9.6% 9.4% 8.8% 9.8% 10.2% 11.0% 11.6% 11.9% 10.8% 9.6% 7.9% 8.4% 8.4% 8.2% 8.4% 8.2% 5.7% 6.1% 6.3% 6.1% 6.3% 6.8% 6.9% 6.7% % 17.1% 7.2% 8.8% 10.2% 8.7% 10.7% 11.0% 10.0% 10.2% 11.4% 9.7% 10.7% 10.2% 10.0% 9.3% 10.3% 10.8% 11.6% 12.2% 12.4% 11.2% 10.0% 8.2% 8.7% 8.7% 8.5% 8.7% 8.5% 5.8% 6.3% 6.5% 6.3% 6.4% 6.9% 7.0% 6.8% % 5.0% 7.9% 9.8% 8.1% 10.5% 10.9% 9.8% 10.0% 11.3% 9.5% 10.6% 10.1% 9.9% 9.1% 10.3% 10.7% 11.6% 12.2% 12.5% 11.2% 9.9% 8.0% 8.6% 8.6% 8.4% 8.6% 8.4% 5.6% 6.1% 6.3% 6.1% 6.3% 6.8% 6.9% 6.7% % 1.1% 5.8% 4.7% 8.2% 9.1% 8.0% 8.5% 10.1% 8.3% 9.6% 9.1% 9.0% 8.2% 9.5% 10.0% 10.9% 11.6% 11.9% 10.7% 9.4% 7.4% 8.0% 8.1% 7.9% 8.0% 7.9% 5.1% 5.6% 5.8% 5.6% 5.8% 6.4% 6.5% 6.3% % 14.8% 10.2% 13.3% 13.4% 11.4% 11.5% 13.0% 10.6% 11.8% 11.1% 10.7% 9.7% 11.0% 11.5% 12.4% 13.1% 13.3% 11.9% 10.4% 8.3% 9.0% 8.9% 8.7% 8.8% 8.6% 5.7% 6.2% 6.4% 6.2% 6.4% 6.9% 7.0% 6.8% % 8.4% 13.2% 13.3% 10.9% 11.1% 12.8% 10.2% 11.6% 10.8% 10.5% 9.4% 10.8% 11.4% 12.3% 13.0% 13.3% 11.8% 10.3% 8.0% 8.7% 8.7% 8.5% 8.6% 8.4% 5.4% 5.9% 6.1% 5.9% 6.1% 6.7% 6.8% 6.6% % 11.8% 12.4% 9.7% 10.1% 12.3% 9.4% 11.0% 10.3% 9.9% 8.8% 10.4% 11.0% 12.1% 12.8% 13.1% 11.6% 10.0% 7.6% 8.4% 8.4% 8.1% 8.3% 8.1% 5.0% 5.5% 5.8% 5.6% 5.8% 6.4% 6.6% 6.3% % 18.4% 12.7% 12.4% 14.7% 10.8% 12.5% 11.4% 10.9% 9.6% 11.3% 11.8% 12.9% 13.7% 14.0% 12.2% 10.5% 8.0% 8.8% 8.8% 8.5% 8.7% 8.4% 5.1% 5.7% 5.9% 5.7% 6.0% 6.6% 6.7% 6.5% % 7.7% 9.0% 12.6% 8.4% 10.8% 9.8% 9.5% 8.2% 10.1% 10.9% 12.1% 13.0% 13.3% 11.5% 9.7% 7.2% 8.0% 8.0% 7.8% 8.0% 7.8% 4.4% 5.0% 5.3% 5.1% 5.4% 6.0% 6.2% 6.0% % 6.7% 12.2% 7.1% 10.2% 9.2% 8.9% 7.5% 9.7% 10.6% 12.0% 12.9% 13.3% 11.4% 9.5% 6.8% 7.7% 7.7% 7.5% 7.7% 7.5% 4.0% 4.7% 5.0% 4.8% 5.1% 5.8% 5.9% 5.7% % 17.7% 8.9% 12.4% 10.7% 10.1% 8.3% 10.7% 11.6% 13.0% 14.0% 14.3% 12.1% 10.0% 7.1% 8.0% 8.1% 7.8% 8.0% 7.8% 4.1% 4.8% 5.1% 4.9% 5.2% 5.9% 6.1% 5.8% % 7.6% 12.6% 10.5% 9.7% 7.8% 10.6% 11.6% 13.2% 14.2% 14.5% 12.2% 9.9% 6.8% 7.8% 7.9% 7.6% 7.8% 7.6% 3.7% 4.5% 4.8% 4.6% 4.9% 5.7% 5.9% 5.6% % 7.2% 6.3% 6.4% 4.8% 8.5% 9.9% 11.9% 13.1% 13.6% 11.1% 8.8% 5.5% 6.7% 6.9% 6.6% 7.0% 6.8% 2.7% 3.6% 4.0% 3.8% 4.2% 5.0% 5.2% 5.0% % 13.5% 11.2% 7.9% 11.9% 12.9% 14.8% 15.9% 16.1% 13.1% 10.3% 6.6% 7.8% 7.9% 7.6% 7.9% 7.6% 3.3% 4.2% 4.5% 4.3% 4.7% 5.5% 5.7% 5.5% % 5.6% 3.2% 9.2% 11.0% 13.5% 14.9% 15.2% 12.0% 9.1% 5.2% 6.6% 6.8% 6.5% 6.9% 6.7% 2.2% 3.2% 3.6% 3.4% 3.9% 4.8% 5.0% 4.8% % 2.5% 10.8% 12.7% 15.4% 16.7% 16.9% 13.0% 9.6% 5.3% 6.9% 7.0% 6.7% 7.1% 6.9% 2.1% 3.1% 3.6% 3.4% 3.8% 4.8% 5.1% 4.8% % 12.8% 14.7% 17.6% 18.8% 18.7% 13.9% 10.0% 5.2% 6.9% 7.0% 6.7% 7.1% 6.9% 1.8% 2.9% 3.4% 3.2% 3.7% 4.7% 5.0% 4.7% % 23.8% 24.8% 24.5% 23.2% 16.7% 11.8% 6.0% 7.8% 7.9% 7.5% 7.9% 7.5% 2.0% 3.2% 3.7% 3.5% 4.0% 5.0% 5.3% 5.0% % 18.5% 22.7% 23.0% 21.7% 14.4% 9.1% 3.1% 5.4% 5.8% 5.5% 6.1% 5.9% 0.2% 1.5% 2.2% 2.1% 2.7% 3.8% 4.2% 3.9% % 25.3% 22.8% 13.4% 7.3% 0.7% 3.7% 4.3% 4.1% 5.0% 4.8% -1.2% 0.3% 1.1% 1.1% 1.7% 3.0% 3.4% 3.2% % 23.6% 20.7% 9.2% 2.9% -3.9% 0.2% 1.4% 1.6% 2.8% 2.8% -3.4% -1.6% -0.6% -0.6% 0.3% 1.7% 2.2% 2.0% % 2.6% -3.3% -9.7% -3.9% -1.9% -1.2% 0.4% 0.8% -5.8% -3.6% -2.4% -2.2% -1.2% 0.4% 1.0% 0.9% % -10.7% -12.3% -17.4% -8.7% -5.4% -4.1% -1.9% -1.2% -8.1% -5.5% -4.1% -3.7% -2.6% -0.8% 0.0% -0.1% % -20.5% -8.0% -4.1% -2.7% -0.3% 0.2% -7.8% -5.0% -3.4% -3.1% -1.9% 0.0% 0.8% 0.7% % -26.6% -4.8% -0.5% 0.3% 2.7% 2.8% -6.9% -3.8% -2.1% -1.9% -0.7% 1.3% 2.0% 1.8% % 15.8% 11.3% 11.7% 10.0% -3.1% 0.0% 1.5% 1.3% 2.4% 4.3% 4.8% 4.4% % 8.6% 5.7% 8.0% 6.9% -7.7% -3.4% -1.3% -1.2% 0.3% 2.6% 3.3% 3.0% % 7.8% 6.3% -11.4% -5.6% -2.9% -2.5% -0.7% 1.9% 2.8% 2.5% % Sold 12.8% 8.0% -15.7% -7.7% -4.0% -3.4% -1.2% 1.8% 2.8% 2.4% 2007 Bought 3.5% -27.1% -13.6% -7.8% -6.3% -3.4% 0.3% 1.6% 1.3% -30% % -21.1% -11.3% -8.6% -4.7% -0.2% 1.3% 1.1% % 16.5% 10.7% 11.2% 14.0% 13.4% 11.3% % 5.8% 8.0% 12.3% 12.0% 9.7% % 6.1% 12.3% 11.9% 9.3% % 19.1% 16.2% 11.7% %--20% -20%--10% -10%-0% 0%-10% 10%-20% 20%-30% 30%-30% 25.9% 18.1% 11.5% % 4.9% %
14 Ave. Annual Return Average Annual return S&P 500 risk stability measures Holding period length: % 7% 6% 25 yr 20 yr 15 yr 10 yr 5 yr 3 yr 2 yr 1 yr 5% 4% 3% 2% 1% 0% 0% 2% 4% 6% 8% 10% 12% 14% 16% 18% 20% St.Dev. of Returns
15 Farmland: Low Equity correlation, positive CPI and Inflation effects C o n t e x t (US Farmland 26 State Returns 3-year rolling holding periods, )
16 Number of Farms 1960-present ERS-USDA
17 Acres per farm increasing ERS-USDA
18 Distribution by Sales Class - - Million Acres - - Ave Farm Sales from up to Farmland '15-'14 Size Ac. % Farmland 1,000 10, % 10, , % 100, , % 250, , , % 500,000 1,000, , % 1,000,000 >1,000, , % Total or ave million %
19 Farm Numbers and Acreage
20 Distribution by Sales Class
21 Size concentration and movement
22 Distribution by farm type and size % of farms % acres % Production # Farms Small Family 89.4% 45.3% 21.5% 1,856,318 MidSize Family 6.1% 23.4% 20.5% 125,760 Large Scale Family 3.4% 27.5% 47.6% 70,930 Non-Family 1.1% 3.8% 10.4% 23,266 Small Type # Farms % farms Retirement 281, Off-Farm 942, Farming low sales 522, Farming med. sales 109, Total Small 1,856, Family Farms comprise 99% of farms and 90% of production. Nearly 90% of farms produce less than $350k per year (Small) Non-family farms only 1% of farms but over 10% of production Source: USDA EIB, Hoppe McDonald (HM)
23 Age (it s complicated ) Slope =.48
24 More complex ops than ownership
25 Ownership and Operations Increasingly separable, but risk profile changes Tax advantaged asset to own into estate Crop Insurance and farm program incentives mixed and increasingly targeted Most corporate farms are family farms age of stockholders may not be meaningful number 2032a and 1031 not ag-specific Fairly concentrated relative to most other sectors Degrees of separation may matter
26 Today s Ag Tech Landscape from Granular s perspective PRECISION AG MACHINE TELEMETRY BENCHMARKING FARM MANAGEMENT SOFTWARE A B G U R S O I N AG ACCOUNTING LIVESTOCK MANAGEMENT SOFTWARE N O E M S Y S 26
27 On-line Comps (free.)
28 Parcel-level attributes (free )
29 Soil map units and acreage (free ) (I actually wondered how to compare to the others in the area that I knew )
30 Crop Histories (free )
31 Valuation app. (free )
32 Common to be asked about future path Is this time different? yes, I think
33 Aggregate US Debt Ratios, US Ag Sector
34 Farm mortgage interest rates and funding relationships 1980s loans could include: 80% LTV, 40-year amortization Ave Spread = 1.29% = 2.53% (-q2:2016)
35 What rates does Fed impact?
36 Interest rate market relatives
37 Percent Acres Insured, U.S.
38 Crop Insurance as Subsidy. Expected 2016 Corn Net Cost Insurance RP85 $/Acre -32 to to -6-6 to 0 0 to 9 9 to to 54 No data
39 Area or Group products Expected 2016 Corn Net Cost Insurance ARP90 $/Acre -84 to to to -4-4 to 7 7 to to 77 No data
40 Probability Impact on lower tail of revenue McLean Co. Illinois -- Corn Enterprise Unit 0.5 Probabilities of Revenue With Insurance $/acre $200 $300 $400 $500 $600 $700 $800 Revenue ($/acre) No Ins. YP85 RP-HPE85 RP85 AYP90 ARP90 ARPHPE90
41 Structural Issues in changing ownership Very low turnover about 1% per year at arm s length in row crop regions Restrictive Farmland Ownership Laws still exist Increasing compliance cost, increasing opportunity Rapidly advancing technical sophistication Future Policy - Farm Bill or Food Bill Institutional interest fits extremely well, but still de minimus scale
42 Changing consumer attribute demand Farm to fork movement - many channels Natural, local, fresh, low impact, etc. competing with certification programs (Organic, GMO-free, gluten free) Lack of standardization in measure of importance (healthfulness, toxicity, taste) and proxy production characteristics
43 Futurecasting Financialization likely to continue for the sector. Equity & indexing vehicles very positive developments Rationalization of recent incomes, lower cap rates Attribute Demand (e.g., non-gmo) becomes more direct public signal, but marginally impacts production key Some positive outcomes for capital providers likely, balance sheet effects unlikely to trigger bubble, low cap rates remain for some time (economy wide, not ag-specific) What asset would you rather own remains important
44 Questions/Discussion Bruce J. Sherrick Find us on the web at:
Fourth Quarter 2017 NCREIF Indices Review February 9, 2018
Fourth Quarter 2017 NCREIF Indices Review February 9, 2018 Panelist Overview Jeff Fisher NCREIF Data & Research Consultant Doug Herzbrun Global Head of Research CBRE Global Investors Disclaimer Today we
More informationThird Quarter 2017 NCREIF Indices Review. Fall Conference November 7, 2017
Third Quarter 2017 NCREIF Indices Review Fall Conference November 7, 2017 Panelist Overview Jeff Fisher NCREIF Data & Research Consultant Sara Rutledge NCREIF Director of Research John Ehli Portfolio Manager
More informationSecond Quarter 2016 NCREIF Indices Review. August 4, 2016 NCREIF-SMU Summer Academy
Second Quarter 2016 NCREIF Indices Review August 4, 2016 NCREIF-SMU Summer Academy Panelist Overview Jeff Fisher NCREIF Data & Research Consultant Sara Rutledge NCREIF Director of Research Mike Sobolik
More informationPortfolio Strategy Group
PSG's Weekly Chart Perspective Portfolio Strategy Group Report Date: Monday, November 15, 21 Daily Close UST 1 Year CMT 5 Year History 5. 4.5 4. 3.5 3. 2.5 2. US Recession Nov-5 Feb-6 May-6 Aug-6 Nov-6
More informationPortfolio Strategy Group
PSG's Weekly Chart Perspective Portfolio Strategy Group Report Date: Monday, September 27, 21 Daily Close UST 1 Year CMT 5 Year History 5. 4.5 4. 3.5 3. 2.5 2. US Recession Sep-5 Dec-5 Mar-6 Jun-6 Sep-6
More informationSummary of Results for the First Half of FY2015/3
Summary of Results for the First Half of FY2015/3 November 10, 2014 Tokyu Corporation (9005) http://www.tokyu.co.jp/ Contents Ⅰ.Executive Summary 2 Ⅱ.Conditions in Each Business 5 Ⅲ.Details of Financial
More informationSecond Quarter 2017 NCREIF Indices Review August 8, 2017
Second Quarter 2017 NCREIF Indices Review August 8, 2017 Panelist Overview Jeff Fisher NCREIF Data & Research Consultant Sara Rutledge NCREIF Director of Research Arthur Jones Director, Commercial Real
More informationCENTRALE. Monetary. compared. domestic. million.
CENTRALE BANK VAN ARUBAA Statistical News Release Second Quarter 2012 Date: November 7, 2012 Monetary and financial developments Money and credit In the second quarterr of 2012, the money supply decreased
More informationWalgreens Pharmacy 2551 W. Main Street Alhambra, CA $10,300,000
Walgreens Pharmacy 2551 W. Main Street Alhambra, CA 91801 $10,300,000 INVESTMENT HIGHLIGHTS Rare LA County, Walgreens Net Leased Offering Population in Excess of 265,328 Within 3 Miles Located Blocks Away
More informationBANK HANDLOWY W WARSZAWIE S.A. 1Q 2009 consolidated financial results -1-
BANK HANDLOWY W WARSZAWIE S.A. 1Q 29 consolidated financial results -1- Macroeconomic situation in 1Q 29 Deep drop in industrial output in January and February, albeit business confidence indicators suggest
More informationInvestor Presentation June 2012 NASDAQ: CEMI
Investor Presentation June 2012 NASDAQ: CEMI Forward-Looking Statements Statements contained herein that are not historical facts are forward-looking statements within the meaning of the Securities Act
More informationFully Employed MBA (MGMT FE)
Fully Employed MBA (MGMT FE) 1 Fully Employed MBA (MGMT FE) Courses MGMT FE 200. Responding to Dynamic Times: Thinking Strategically in Organizations. 6 Units. Focuses on the strategic and organizational
More informationHow Residential Development Gets Financed
How Residential Development Gets Financed Raquel Favela, Chief of Economic Development & Neighborhood Services Jackie Rodarte, Assistant Director, Housing & Neighborhood Revitalization 1 Understanding
More informationTelekom Austria Group Results for the 1st Quarter May 27, 2003
Telekom Austria Group Results for the 1st Quarter 2003 May 27, 2003 1 Cautionary Statement This presentation contains certain forward-looking statements. Actual results may differ materially from those
More informationWelcome to LG Electronics
Welcome to LG Electronics April 21, 2004 As a note, this presentation has been prepared based on internal audited figures and final figures may change due to the results of independent auditors review.
More informationMANAGEMENT. MGMT 0021 THE MANAGEMENT PROCESS 3 cr. MGMT 0022 FINANCIAL ACCOUNTING 3 cr. MGMT 0023 MANAGERIAL ACCOUNTING 3 cr.
MANAGEMENT MGMT 0021 THE MANAGEMENT PROCESS 3 cr. An introduction designed to emphasize the basic principles, practices, and terminology essential to the understanding of contemporary business and its
More informationForward-Looking Statements
Investor Presentation May 2012 Forward-Looking Statements Statements contained herein that are not historical facts are forward-looking statements within the meaning of the Securities Act of 1933, as amended.
More informationThe Verde Mountain Fund offers a unique opportunity to gain early entry into one of the fastest growing industries in a generation.
The Verde Mountain Fund offers a unique opportunity to gain early entry into one of the fastest growing industries in a generation. The Verde Mountain Fund offers a unique investment opportunity for both
More informationMonday, September 11 Start Time End Time Session Type Product Focus Session name 8:00 am 12:00 pm Training Axys, APX APX/Axys Advanced Report Writer
Monday, September 11 8:00 am 12:00 pm Training Axys, APX APX/Axys Advanced Report Writer Pro Master Class ($395.00) 8:00 am 12:00 pm Training Precision LM Precision LM Database Structure ($395.00) 8:00
More informationHigh Value Soybean Composition
Fact Sheet #39 November 23, 1998 Purdue University High Value Soybean Composition Dirk E. Maier, Jason Reising, & Jenni L. Briggs, Agricultural & Biological Engineering Kelly M. Day & Ellsworth P. Christmas,
More informationEconomic Impact of Highly Pathogenic Avian Influenza (HPAI) on Poultry in Iowa
Economic Impact of Highly Pathogenic Avian Influenza (HPAI) on Poultry in Iowa Prepared For: Prepared By: August 2015 Table of Contents Executive Summary... 3 Background... 4 Methodology... 10 IMPLAN Model
More informationTable Egg Industry Outlook
Agricultural Finance Table Egg Industry Outlook Executive summary Table egg prices have experienced increased volatility over the past two years. Avian flu decimated layer flocks in 05, and in response,
More informationZacks Small-Cap Research
Zacks Small-Cap Research Sponsored Impartial - Comprehensive August 29, 2018 David Bautz, PhD 312-265-9471 dbautz@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Opiant Pharmaceuticals,
More informationVisionary Private Equity Group is Pleased to Announce its Investment in MEDITE Cancer Diagnostics
Dear VPEG Limited Partner, We hope this investor update finds you well. We're pleased to share with you an important update below on the following: Visionary Private Equity Group is Pleased to Announce
More informationAltria Group Inc. Ticker: MO
Altria Group Inc. Ticker: MO Business Description Altria Group Inc. through its subsidiaries manufactures and sells cigarettes, other tobacco products, machine-made large cigars and pipe tobacco. It also
More informationQ Investor Kit JANUARY-JUNE 2013
Q2 2013 Investor Kit JANUARY-JUNE 2013 1 Swedish Match reporting segments Snus and snuff - Swedish snus (Scandinavia and US) - Moist snuff (US) - SMPM International Other tobacco products - Cigars (US)
More informationUroplasty, Inc. Investor Update Canaccord Genuity Conference December 6, 2011
Uroplasty, Inc. Investor Update Canaccord Genuity Conference December 6, 2011 Forward Looking Statement This presentation includes forward-looking statements, including financial projections, relating
More informationPRIME investment opportunity in Beverly Hills S. Roxbury Dr. Beverly Hills, CA 90212
PRIME investment opportunity in Beverly Hills One of the highest-profile and most sought-after locations in the world! The Roxbury address has enormous cache and is within walking distance to everything
More informationSeller-financing opportunity in Redondo 2408 Grant Ave Redondo Beach, CA 90278
Seller-financing opportunity in Redondo Large, all electric units in a highly visible location Grant is a main artery that runs the length of North Redondo Well-maintained by original owner! NEVER been
More informationThe Effects of Soybean Protein Changes on Major Agricultural Markets
The Effects of Soybean Protein Changes on Major Agricultural Markets Prem V. Premakumar Working Paper 96-WP 16 June 1996 Center for Agricultural and Rural Development Iowa State University Ames, Iowa 511-17
More informationColoplast A/S. Investor presentation 1H 2005/06
Coloplast A/S Investor presentation 1H 2005/06 2 Coloplast Coloplast products and services help patients achieve greater independence from medical challenges in 4 areas: Ostomy care, continence care, wound
More informationREATA PHARMACEUTICALS, INC. ANNOUNCES SECOND QUARTER 2018 FINANCIAL RESULTS AND AN UPDATE ON DEVELOPMENT PROGRAMS
REATA PHARMACEUTICALS, INC. ANNOUNCES SECOND QUARTER 2018 FINANCIAL RESULTS AND AN UPDATE ON DEVELOPMENT PROGRAMS IRVING, Texas August 8, 2018 Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a clinical-stage
More informationDirector of Donor Partnerships
TULSA Community Foundation Tulsa Community Foundation (TCF) was founded in late 1998 and exists to make charitable giving more meaningful and efficient. Hundreds of individuals and corporations make all
More informationWntResearch. 100% one-week return? 16 October 2017 PRICE EXPECTATIONS INVESTMENT CASE PRICE TRIGGERS PRICE 12 MONTHS COMPANY PROFILE
Occasion: Initial coverage +37% +71% 100% one-week return? s share price has dropped by more than 50% since the announcement of the current and ongoing public offering. In theory the share price should
More informationDELICA D:5 ACTIVE GEAR 0
DELICA D:5 ACTIVE GEAR 0 1 1. FY2017 1Q Results 2. FY2017 1Q Results by Region 3. FY2017 Forecast 4. Initiatives for the Future FY2017 1Q Results Summary (vs. FY2016 1Q) (Apr-Jun 2016) (Apr-Jun 2017) (billion
More informationSPHERIX ANNOUNCES FIRST QUARTER 2010 FINANCIAL RESULTS
SPHERIX Investor Relations Phone: (301) 897-2564 Email: info@spherix.com SPHERIX ANNOUNCES FIRST QUARTER 2010 FINANCIAL RESULTS BETHESDA, MD, May 21, 2010 - Spherix Incorporated (NASDAQ CM: SPEX), an innovator
More informationCRS Report for Congress Received through the CRS Web
Order Code 95-129 ENR Updated November 3, 2003 CRS Report for Congress Received through the CRS Web Tobacco Price Support: An Overview of the Program Jasper Womach Agricultural Policy Specialist Resources,
More informationWntResearch. Pearls on a string. 3 September 2018 PRICE EXPECTATIONS INVESTMENT CASE PRICE TRIGGERS PRICE 12 MONTHS COMPANY PROFILE
Occasion: Company announcements +32% +58% Pearls on a string has had troublesome times, but now everything seems to fall into place. With a new CEO in charge the phase II trials close to commencing in
More informationSponsors. Editors W. Christopher Scruton Stephen Claas. Layout David Brown
Sponsors University of Minnesota College of Veterinary Medicine College of Agricultural, Food and Environmental Sciences Extension Service Swine Center Editors W. Christopher Scruton Stephen Claas Layout
More informationSmall-Cap Research. VolitionRx Ltd (VNRX-NYSE) VNRX: More Positive Data in Colon/Lung Cancers. Anticipating Initial Launch This Year OUTLOOK
Small-Cap Research February 2, 2016 Brian Marckx, CFA bmarckx@zacks.com Ph (312) 265-9474 scr.zacks.com 10 S. Riverside Plaza, Ste 1600, Chicago, IL 60606 VolitionRx Ltd (VNRX-NYSE) VNRX: More Positive
More informationGrowth in core businesses offsets weaker non-interest income. DBS Group Holdings 1Q 2005 Financial Results Presentation to Media and Analysts
Growth in core businesses offsets weaker non-interest income April 29, 2005 DBS Group Holdings 1Q 2005 Financial Results Presentation to Media and Analysts This presentation is available at www.dbs.com/investor
More informationImpact of excise tax on price, consumption and revenue
Impact of excise tax on price, consumption and revenue Introduction Increase in tobacco tax that leads to price increase is expected to reduce tobacco consumption and improve public health. This section
More informationSTATE OF NORTH DAKOTA PUBLIC SERVICE COMMISSION FINDINGS OF FACT, CONCLUSIONS OF LAW AND ORDER. June 27, Appearances
STATE OF NORTH DAKOTA PUBLIC SERVICE COMMISSION Northern States Power Company Natural Gas Rate Increase Application FINDINGS OF FACT, CONCLUSIONS OF LAW AND ORDER June 27, 2001 Appearances Commissioners:
More informationQ Investor Kit JANUARY-MARCH 2013
Q1 2013 Investor Kit JANUARY-MARCH 2013 1 Swedish Match reporting segments Snus and snuff - Swedish snus (Scandinavia and US) - Moist snuff (US) - SMPM International Other tobacco products - Cigars (US)
More informationDIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM
November 28, 2017 DIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM Dr. Jürgen Wunram Agenda Diebold Nixdorf AG History and shareholder structure Market trends, strategy and progress of integration Diebold Nixdorf
More informationM e d i a s e t G r o u p
M e d i a s e t G r o u p 11 th May 2004 2004 First Quarter Results M e d i a s e t G r o u p BROADCASTING MEDIASET 2004 1Q 24 Hours Audience Trend Individuals Share Points Vs 1Q 2003 OTHER SATELLITE 44.0%
More information6.00% CAP Rate $5,600,000. DeerfieldPartners. John Giordani Art Griffith (415) Actual Store
Actual Store Low Price & Great Value $5,6, 6.% CAP Rate Open & paying rent--available for immediate sale Lower price point and great value Offered free & clear; loans available today with as little as
More information1Q Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes
1Q 2015 Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes Forward-Looking Statements and Copyright This Presentation includes and is based, inter alia, on forward-looking information and statements
More informationXXII: CTP Summarizes Scientific Case for Limiting Nicotine in Cigarettes. Company Update October 15, 2018 Industrial & Consumer Technology
Company Update Industrial & Consumer Technology (XXII - $2.81 - Buy) COMPANY NOTE JAMES McILREE, CFA, Senior Research Analyst, +1-646-465-9034 jmcilree@chardan.com Sales and trading 7 a.m. to 7 p.m. ET,
More informationAcquisition of Novartis Influenza Vaccines Business. 27 th October 2014
1 Acquisition of Novartis Influenza Vaccines Business 27 th October 2014 2 Legal Notice Forward looking statements The materials in this presentation speak only as of the date of these materials, and include
More informationShareholder Presentation Annual Meeting 2018
Shareholder Presentation Annual Meeting 2018 FY 18 HIGHLIGHTS Strong sales growth of 2 nd Gen TruScreen to China commenced during 4 th quarter. (50% of the year s sales were generated in the fourth quarter)
More informationINVESTOR PRESENTATION
INVESTOR PRESENTATION JUNE 2016 OTCQB:CANN ABOUT General Cannabis Corporation (GCC) is the all-in-one resource for the highest quality service providers available to the regulated Cannabis Industry. We
More informationMETVIX PDT ON THE MARKET IN GERMANY AND UK
METVIX PDT ON THE MARKET IN GERMANY AND UK PhotoCure ASA First Quarter Report 2003 Highlights: The launches of Metvix PDT by Galderma in February in Germany and in May in the UK, have triggered milestone
More informationVICAL INC FORM 8-K. (Current report filing) Filed 11/02/06 for the Period Ending 11/02/06
VICAL INC FORM 8-K (Current report filing) Filed 11/02/06 for the Period Ending 11/02/06 Address 10390 PACIFIC CENTER COURT. SAN DIEGO, CA 92121-4340 Telephone 858-646-1100 CIK 0000819050 Symbol VICL SIC
More informationARUBA RECENT ECONOMIC DEVELOPMENTS AND OUTLOOK. Presented by Jane R. Semeleer President Centrale Bank van Aruba May 30, 2011
ARUBA RECENT ECONOMIC DEVELOPMENTS AND OUTLOOK Presented by Jane R. Semeleer President Centrale Bank van Aruba May 30, 2011 STRUCTURE 1. National economy 2. International economy 3. Outlook 2 CENTRALE
More informationExtremely Rare 24 hour Store Huntington Beach, CA
Extremely Rare 24 hour Store Huntington Beach, CA Actual Store Exclusively Listed Investment Offering Absolute NNN Walgreens in Huntington Beach, CA. High traffic location with average household income
More informationcommercial real estate
August 15 Asset Management Documeent title on one or two Defensive lines in Gustan investing Book in pt U.S. commercial real estate TIAA-CREF Global Real Estate Strategy & Research Martha Peyn, Ph.D. Managing
More informationMortgage Rate Sheet Intermediary Rate Sheet Rates Effective From 15th December 2017
Mortgage Sheet Intermediary Sheet s Effective From 15th December 2017 Contents s... Purchase, 4 & 5...2,3 Family Spingboard & Help to Buy Purchase s...5...2,3, 4 & 5 s...6,7 Family Spingboard, Scotland
More informationTobacco Consumption in the United States, 1880 to By Benno K. Milmore and Arthur G. Conover
Consumption in the United States, 88 to 954 By Benno K. Milmore and Arthur G. Conover The trend of cigarette consumption in the United States in recent years has been the subject of much comment and speculation.
More informationIowa s Changing Swine Industry
Animal Industry Report AS 652 ASL R2158 2006 Iowa s Changing Swine Industry Mark S. Honeyman Iowa State University, honeyman@iastate.edu Michael D. Duffy Iowa State University Recommended Citation Honeyman,
More informationMannKind Corporation. BAEZ & IPE Inc. Inhaled Insulin: Next Generation Diabetes Therapy
Millions of Shares BAEZ & IPE Inc. MannKind Corporation Inhaled Insulin: Next Generation Diabetes Therapy Afresa is well positioned to capture the inhaled insulin segment and to cut into the short-acting
More informationGroup financial results for the first quarter 2008
Helmut Perlet, Member of the Board of Management Group financial results for the first quarter 2008 Journalists Conference Call May 9th, 2008 Group: robust earnings in stormy weather (EUR mn) Quarterly
More informationInterim report Second quarter 2017 and subsequent events (Unaudited)
SERODUS ASA Interim report Second quarter 2017 and subsequent events (Unaudited) August 2017 2017-08-15 Q2-2017 report ABOUT SERODUS Serodus is a private biotech company with a focus on diabetic comorbidities
More informationCPH Chemie + Papier Holding AG. Investor Day. Perlen, 13 th September 2018
CPH Chemie + Papier Holding AG Investor Day Perlen, 13 th September 2018 Agenda 2.00 pm Welcome 2.05 pm Presentation Course of Business 2018 2.50 pm Break 3.00 pm Presentation Perlen Packaging 3.30 pm
More informationCritical Access Hospital Medicare Reimbursement Update and Financial Improvement Tools
acumen Critical Access Hospital Medicare Reimbursement Update and Financial Improvement Tools Presented by Ann King White, CPA & Tammy Rivera, CPA BKD, LLP January 16, 2018 insight ideas attention reach
More informationMercy Health Corporation (WI)
Mercy Health Corporation (WI) 1 Illinois Finance Authority, Revenue Bonds (Mercy Health Corporation), Series, $475,020,000, Dated: May 18, 2 Wisconsin Health and Educational Facilities Authority, Revenue
More informationOraSure Technologies. JEFFERIES 2014 GLOBAL HEALTHCARE CONFERENCE June 4, 2014
OraSure Technologies JEFFERIES 2014 GLOBAL HEALTHCARE CONFERENCE June 4, 2014 Forward-Looking Statements These slides and the associated presentation contain certain forward-looking statements, including
More informationNOVO NORDISK. Analyst: Recommendation: HOLD DATE: Industry: Drug manufacturers
NOVO NORDISK Analyst: Recommendation: HOLD DATE: 11.11.2015 Industry: Drug manufacturers Share price 375,00 DKK Homepage www.novonordisk.com Ticker NVO Number of shares (000) 2.563.800 Target price 406,14
More informationSilicon Valley Housing and Economic Outlook
White Paper Silicon Valley Housing and Economic Outlook Santa Clara County, San Mateo County Prepared by John Burns Real Estate Consulting for Pacific Union 11.5.2014 Santa Clara County The booming tech
More informationNASDAQ: FHCO 2016 Annual Meeting
NASDAQ: FHCO 2016 Annual Meeting Q1 2016 At a Glance NASDAQ Core product FHCO FC2 Female Condom Gross margin ~66% Operating margin ~29% Total current assets $24 million no L/T debt Profitable Starting
More informationWalgreen Co. Reports Second Quarter 2010 Earnings Per Diluted Share of 68 Cents; Results Include 2 Cents Per Diluted Share of Restructuring Costs
Walgreen Co. Reports Second Quarter 2010 Earnings Per Diluted Share of 68 Cents; Results Include 2 Cents Per Diluted Share of Restructuring Costs Second quarter sales up 3.1 percent to record $17.0 billion
More informationInvesting in Dental Practice Management: Key Issues and Notable Transactions
Investing in Dental Practice Management: Key Issues and Notable Transactions SCOTT BECKER, PARTNER 312.750.6016 sbecker@mcguirewoods.com 77 West Wacker Drive, Suite 4100 Chicago, Illinois 60601 LAURALEE
More informationMDxHealth. Strong outlook for Research Note.
Research Note MDxHealth Strong outlook for 2017 Chief Research Analyst Marcel Wijma MSc +1 (917) 460 6185 (US) +31 (6) 8489 2954 (NL) m.wijma@leeuwenhoeck.com http://www.leeuwenhoeck.com Date: 23 February
More informationHyundai Motor Company 1 st Quarter 2011 Business Results. April 28, 2011
Hyundai Motor Company 1 st Quarter 2011 Business Results April 28, 2011 Cautionary Statement with Respect to Forward-Looking Statements In the presentation that follows and in related comments by Hyundai
More informationTobacco Product Regulation: FDA s Economic Impact Analysis Frank J. Chaloupka University of Illinois at Chicago
Tobacco Product Regulation: FDA s Economic Impact Analysis Frank J. Chaloupka University of Illinois at Chicago American Heart Association/American Stroke Association Advocacy Coordinating Committee Dallas
More informationFor personal use only
Cochlear Limited Results for the half year ended 31 December 2011 (H1 F12) Chris Roberts, CEO Neville Mitchell, CFO Cochlear Overview Cochlear Limited (ASX:COH): global leader in implantable devices for
More informationInvestment in MGC Pharmaceuticals
Investment in MGC Pharmaceuticals Investor Presentation May 2015 Disclaimer This presentation has been prepared by Erin Resources Limited ( Company ). It does not purport to contain all the information
More informationThe Strategic Marketing Institute Working Paper
The Strategic Marketing Institute Working Paper The Market for Organic and Fortified Eggs William A. Knudson 2-0104 January 2004 Introduction Eggs are an important part of the American diet. According
More informationFIRST QUARTER 2018 RESULTS 15 MAY 2018 LUCA BETTONTE, CEO
FIRST QUARTER 2018 RESULTS 15 MAY 2018 LUCA BETTONTE, CEO DISCLAIMER This document contains certain forward-looking information that is subject toa number of factors that may influence the accuracy of
More informationResults Briefing. 15 ~ 17 May 2007
Results Briefing 1Q Q & 3 Months ended 31 Mar. 2007 15 ~ 17 May 2007 Content Key highlights Financial Corporate Financial results Industry overview Q&A Appendix 2 2 Key Highlights for the Period Key Highlights
More informationFarm Level Effects an Increase in Federal Cigarette Taxes under Two Scenarios: Keep vs Eliminate the Tobacco Program
U.S. Department of Agriculture Agricultural Outlook Forum 1998 February 23 & 24, 1998 Farm Level Effects an Increase in Federal Cigarette Taxes under Two Scenarios: Keep vs Eliminate the Tobacco Program
More information1Q2017 法人說明會 Jun. 9, 2017
1Q2017 法人說明會 Jun. 9, 2017 FE group business Span over 10 major industries Own over 240 companies Established in 1937 9 public listed companies in Taiwan and HK Petrochemical & energy Polyester & synthetic
More informationNORTH AMERICAN DERMATOLOGY. M&A Activity and Valuation Trends Q Robert Ullman Managing Director
Robert Ullman Managing Director rullman@dinancapital.com 45.63.44 NORTH AMERICAN DERMATOLOGY M&A Activity and Valuation Trends Q4 205 William Downing Director wdowning@dinancapital.com 602.734.0682 Michael
More informationSmall-Cap Research. VolitionRx Ltd (VNRX-OTC) VNRX: 938-Sample Set Supports Earlier Findings of High Accuracy in Colon Cancer Detection OUTLOOK
Small-Cap Research September 12, 2014 Brian Marckx, CFA bmarckx@zacks.com Ph (312) 265-9474 scr.zacks.com 10 S. Riverside Plaza, Ste 1600, Chicago, IL 60606 VolitionRx Ltd (VNRX-OTC) VNRX: 938-Sample Set
More informationEmisphere Technologies, Inc. Announces 2008 Second Quarter Financial Results
August 11, 2008 Emisphere Technologies, Inc. Announces 2008 Second Quarter Financial Results Conference Call/Webcast to be Held Monday, August 11 at 10:00 AM EDT CEDAR KNOLLS, N.J., Aug 11, 2008 /PRNewswire-FirstCall
More informationVITROLIFE AB (PUBL) NORDEA Small & Mid Cap Seminar
VITROLIFE AB (PUBL) NORDEA Small & Mid Cap Seminar 2018-08-16 1 2 10 15 % OF ALL COUPLES IN FERTILE AGE SUFFER FROM FERTILITY PROBLEMS LEADING COMPANY IN MEDICAL DEVICES FOR ASSISTED REPRODUCTION A Swedish
More informationPresentation First quarter 2006
Immunity for Life TM Presentation First quarter 2006 CEO Gunnar Rørstad CFO Finn Samuelsen 10 May 2006 Highlights - operations Inclusion of patients almost completed in the the phase II clinical trial
More informationInvestor Presentation
Investor Presentation January 2012 Forward Looking Statements Statements contained herein that are not historical facts are forward-looking statements within the meaning of the Securities Act of 1933,
More informationSuccessful Senior Marketing Sales Support Materials
Successful Senior Marketing Sales Support Materials 1. Contents of This DVD DVD Table of Contents PDF 2. Slide Presentation System Slide Set #1 The Challenges of Growing Older PPT Slide Set #2 Aging Seniors
More informationMerrill Lynch's Global Pharmaceutical, Biotechnology, and Medical Device Conference. February 7, 2007
Merrill Lynch's Global Pharmaceutical, Biotechnology, and Medical Device Conference February 7, 2007 Information related to forward-looking statements This presentation includes forward-looking statements
More informationHALOZYME REPORTS SECOND QUARTER 2018 RESULTS
Contacts: Robert H. Uhl Managing Director Westwicke Partners, LLC 858-356-5932 robert.uhl@westwicke.com Laurie Stelzer 858-704-8222 ir@halozyme.com FOR IMMEDIATE RELEASE HALOZYME REPORTS SECOND QUARTER
More informationWalgreens. Absolute NNN Single Tenant - Bastrop, LA. Offering Memorandum. Beezie Landry
Beezie Landry 109 Northpark Blvd., Ste. 300 Covington, LA 70433 985-898-2022 blandry@stirlingprop.com Walgreens Absolute NNN Single Tenant - Offering Memorandum 1 information to the extent such purchaser/lessee
More informationA GLOBAL LEADER IN PERSONALIZED NUTRITION
A GLOBAL LEADER IN PERSONALIZED NUTRITION Forward Looking Statements Management will make forward-looking statements during this presentation. Actual results could differ from those projected in such forward-looking
More informationSmall-Cap Research. Diffusion Pharmaceuticals Inc. (DFFN-NASDAQ) DFFN: FDA Gives Final Guidance for Phase 3 Protocol for TSC in Inoperable GBM OUTLOOK
Small-Cap Research November 16, 2017 David Bautz, PhD 312-265-9471 dbautz@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Diffusion Pharmaceuticals Inc. (DFFN-NASDAQ) DFFN: FDA Gives Final
More informationRoof Type: Roof Material: Foundation: Ext. Material: Exterior: Patio: 0 Garage: Heat Source: Fireplace #: 0 BldgCondition: Neighborhood:
Parcel #: 26488 Ref Parcel #: 7329DB 22 Owner: CoOwner: Owner Phone: Site: Mail: Legal: School Dist: Brill Investments LLC POLK COUNTY PROPERTY PROFILE INFORMATION 2625 Salem Dallas Hwy NW SalemOR9734
More informationProject for Alternative Livelihoods in Eastern Afghanistan (PAL)
Project for Alternative Livelihoods in Eastern Afghanistan (PAL) 1 Understanding Rural Livelihoods and Addressing the Causes of Opium Poppy Cultivation in Eastern Afghanistan Abridged Version 1. Introduction
More informationQUALITAS MEDICAL GROUP LIMITED. CORPORATE PRESENTATION January 2010
QUALITAS MEDICAL GROUP LIMITED CORPORATE PRESENTATION January 2010 Contents Our Business Corporate Developments Growth Strategies Financial Highlights Summary Business Overview Who We Are Established in
More informationIndustry experience in consortium i.e. from BEE party or non-bee partners
A. ENTREPRENEURSHIP FINANCE Imbewu Entrepreneurship Finance would provides risk capital to new businesses and to early stage businesses owned and managed by black people meeting the following criteria:
More information